Axithra provides rapid therapeutic drug monitoring (TDM) services at the point of need. The company focuses on saving patients' lives and improving outcomes through rapid drug monitoring, offering clinically actionable results tailored to individual patients.

Axithra

Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time. The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments.

I'm delighted to announce that we're strengthening our board of directors. Alain Pluquet, PhD and Michael Tillmann have been appointed as chairman and independent director, respectively

Axithra is hiring a talented Systems Engineer to strengthen our R&D team in Ghent. If you're interested to help shape the future of healthcare and diagnostics, please apply on our website (https://lnkd.in/eQGCcVng)

Kicking off #hellotomorrow with a very warm welcome at a great venue in Paris

Axithra is Presenting at the HealthTech Investor Summit on 6 December

Axithra is hiring! We're looking for a talented Photonics Engineer to strengthen R&D team in Ghent. If you're interested to help shape the future of healthcare and diagnostics, please apply on our website (https://lnkd.in/gsDTXc96)

Axithra is hiring! We're looking for a talented chemist to strengthen our Ghent-based R&D team. If you're interested to help shape the future of healthcare and diagnostics, please send your resume and motivation letter to hr@axithra.com

AXIT

COM:AXITHRA

Axithra